Logan Capital Management’s GSK GSK Stock Holding History

Logan Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-114,917	Closed	-$6.23M	–	377
2025 Q4	$5.64M	Buy	114,917 +10,490	+10%	+$489K	0.24%	108
2025 Q3	$4.51M	Buy	104,427 +10,183	+11%	+$398K	0.19%	128
2025 Q2	$3.62M	Buy	94,244 +8,085	+9%	+$309K	0.17%	135
2025 Q1	$3.34M	Buy	86,159 +1,496	+2%	+$54.8K	0.15%	138
2024 Q4	$2.86M	Buy	84,663 +740	+0.9%	+$26.6K	0.12%	158
2024 Q3	$3.43M	Buy	83,923 +3,083	+4%	+$126K	0.14%	146
2024 Q2	$3.11M	Sell	80,840 -2,549	-3%	-$107K	0.13%	153
2024 Q1	$3.57M	Buy	83,389 +3,841	+5%	+$158K	0.15%	141
2023 Q4	$2.95M	Buy	79,548 +2,897	+4%	+$104K	0.14%	154
2023 Q3	$2.78M	Buy	76,651 +3,804	+5%	+$135K	0.14%	148
2023 Q2	$2.6M	Buy	72,847 +60,143	+473%	+$2.16M	0.12%	154
2023 Q1	$452K	Hold	12,704	–	–	0.02%	255
2022 Q4	$446K	Buy	+12,704	New	+$423K	0.02%	253
2022 Q3	–	Sell	-12,704	Closed	-$691K	–	514
2022 Q2	$691K	Hold	12,704	–	–	0.04%	230
2022 Q1	$691K	Hold	12,704	–	–	0.03%	239
2021 Q4	$700K	Sell	12,704 -3	-0%	-$156	0.03%	242
2021 Q3	$607K	Hold	12,707	–	–	0.03%	247
2021 Q2	$632K	Buy	12,707 +3	+0%	+$144	0.03%	243
2021 Q1	$567K	Sell	12,704 -19,043	-60%	-$864K	0.03%	243
2020 Q4	$1.46M	Sell	31,747 -1,159	-4%	-$53.2K	0.07%	177
2020 Q3	$1.55M	Buy	32,906 +1,164	+4%	+$58.3K	0.08%	202
2020 Q2	$1.62M	Buy	31,742 +794	+3%	+$40.7K	0.09%	149
2020 Q1	$1.47M	Sell	30,948 -618	-2%	-$33K	0.1%	160
2019 Q4	$1.85M	Buy	31,566 +228	+0.7%	+$12.7K	0.1%	149
2019 Q3	$1.67M	Buy	31,338 +1,981	+7%	+$102K	0.1%	154
2019 Q2	$1.47M	Buy	29,357 +619	+2%	+$31.1K	0.09%	158
2019 Q1	$1.5M	Sell	28,738 -1,510	-5%	-$75.5K	0.09%	153
2018 Q4	$1.44M	Buy	30,248 +48	+0.2%	+$2.36K	0.11%	133
2018 Q3	$1.52M	Sell	30,200 -525	-2%	-$26.7K	0.1%	141
2018 Q2	$1.55M	Buy	30,725 +635	+2%	+$32K	0.11%	133
2018 Q1	$1.47M	Buy	30,090 +4,536	+18%	+$211K	0.1%	131
2017 Q4	$1.13M	Sell	25,554 -8,412	-25%	-$389K	0.08%	158
2017 Q3	$1.72M	Buy	33,966 +1,680	+5%	+$85.2K	0.12%	118
2017 Q2	$1.74M	Sell	32,286 -494	-2%	-$26.3K	0.13%	115
2017 Q1	$1.73M	Sell	32,780 -1,836	-5%	-$93.1K	0.13%	114
2016 Q4	$1.67M	Sell	34,616 -719	-2%	-$35.5K	0.13%	114
2016 Q3	$1.91M	Buy	35,335 +406	+1%	+$22.3K	0.16%	108
2016 Q2	$1.89M	Buy	34,929 +128	+0.4%	+$6.74K	0.16%	105
2016 Q1	$1.76M	Sell	34,801 -20,059	-37%	-$999K	0.14%	115
2015 Q4	$2.77M	Sell	54,860 -1,265	-2%	-$64.5K	0.22%	94
2015 Q3	$2.7M	Sell	56,125 -3,717	-6%	-$193K	0.22%	95
2015 Q2	$3.12M	Sell	59,842 -171,506	-74%	-$9.66M	0.23%	96
2015 Q1	$13.3M	Buy	231,348 +9,567	+4%	+$548K	0.94%	43
2014 Q4	$11.8M	Buy	221,781 +23,688	+12%	+$1.33M	0.86%	48
2014 Q3	$11.4M	Buy	198,093 +9,380	+5%	+$575K	0.82%	49
2014 Q2	$12.6M	Buy	188,713 +3,463	+2%	+$234K	0.89%	48
2014 Q1	$12.4M	Buy	185,250 +8,259	+5%	+$558K	0.89%	45
2013 Q4	$11.8M	Buy	176,991 +35,197	+25%	+$2.28M	0.84%	45
2013 Q3	$8.89M	Buy	141,794 +11,815	+9%	+$761K	0.67%	57
2013 Q2	$7.4M	Buy	+129,979	New	+$8.25M	0.6%	59

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Logan Capital Management's GSK Position: Q1 2026 in Review

Logan Capital Management sold out of GSK (GSK) in Q1 2026, closing a stake of 114,917 shares — an estimated $6.23M sold.

Logan Capital Management first reported a position in GSK in Q2 2013 and held it in 50 quarters. The position peaked at $13.3M in Q1 2015. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Logan Capital Management reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Logan Capital Management sold 114,917 GSK shares in Q1 2026, an estimated $6.23M.
Logan Capital Management first reported a position in GSK in Q2 2013 and held it in 50 quarters.
Logan Capital Management's GSK position peaked at $13.3M in Q1 2015.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.